Cowen initiated coverage on shares of BridgeBio Pharma (NASDAQ:BBIO – Get Rating) in a research report report published on Monday morning, Briefing.com reports. The firm issued an outperform rating on the stock. Several other research analysts also recently weighed in on the stock. SVB Leerink decreased their target price on shares of BridgeBio Pharma from […]
Check out "The Pat & Aaron Show Injury Report" with Dr. Neil Kumar from the Florida Orthopedic Institute, as he calls in for the weekly segment. The topics include CJ Gardner-Johnson, Tristan Wirfs, Eddie Jackson, Najee Harris, and more.
03.11.2022 - - Reported positive preclinical data for its next-generation KRASG12C GTP/GDP dual inhibitor development candidate, BBO-8520, and for its novel PI3Kα:RAS breaker mechanism in late lead optimization - Reported positive updated 12-month Phase 2 data .
/CNW/ - Richardson Wealth Limited (Richardson Wealth), a wholly owned subsidiary of RF Capital Group Inc. (TSX: RCG) (RF Capital), is honoured to announce that.